DexCom director Glenn S. Boehnlein files initial beneficial ownership statement
DXCM•Initial ownership filing
- DexCom director Glenn S. Boehnlein reported 42 shares of common stock held indirectly via a trust in an initial ownership filing dated 09/10/2026.*
